T1	Disease 80 88	COVID-19
T2	OrganismPart 91 100	Platelets
T3	Disease 6103 6111	COVID-19
T4	Disease 6131 6138	healthy
T5	OrganismPart 6347 6352	blood
T6	OrganismPart 7308 7317	platelets
T7	NumberOfFractions 8306 8311	Three
T8	FractionIdentifier 8350 8360	Fraction 1
T9	FractionationFraction 8368 8383	plasma proteins
T10	FractionIdentifier 8386 8396	Fraction 2
T11	FractionIdentifier 8417 8427	Fraction 3
T12	FractionationFraction 8405 8414	platelets
T13	FractionationFraction 8435 8450	large platelets
T14	SupplementaryFile 21767 21774	Table 1
T15	Age 21617 21620	age
T16	Sex 21626 21629	sex
R1	IsInSuppl Arg1:T15 Arg2:T14	
R2	IsInSuppl Arg1:T16 Arg2:T14	
T17	NumberOfSamples 21762 21764	16
T18	ReductionReagent 9611 9625	dithiothreitol
T19	AlkylationReagent 9711 9724	iodoacetamide
T20	CleavageAgent 10750 10757	trypsin
T21	AcquisitionMethod 12026 12052	Data-Dependent Acquisition
T22	IonizationType 13023 13035	electrospray
T23	Instrument 13078 13137	Orbitrap Fusion(TM) Lumos(TM) Tribrid(TM) Mass Spectrometer
T24	AcquisitionMethod 13416 13442	data-dependent acquisition
T25	AcquisitionMethod 13444 13447	DDA
T26	AcquisitionMethod 12054 12057	DDA
*	Equiv T21 T26
*	Equiv T24 T25
T27	FragmentationMethod 13487 13525	higher-energy collisional dissociation
T28	FragmentationMethod 13527 13530	HCD
*	Equiv T27 T28
T29	CollisionEnergy 13549 13552	28%
T31	MS2MassAnalyzer 13866 13874	orbitrap
